364 related articles for article (PubMed ID: 27831558)
21. Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.
Tan S; Zhao J; Sun Z; Cao S; Niu K; Zhong Y; Wang H; Shi L; Pan H; Hu J; Qian L; Liu N; Yuan J
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14231-14242. PubMed ID: 32513687
[TBL] [Abstract][Full Text] [Related]
22. MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death.
Jaco I; Annibaldi A; Lalaoui N; Wilson R; Tenev T; Laurien L; Kim C; Jamal K; Wicky John S; Liccardi G; Chau D; Murphy JM; Brumatti G; Feltham R; Pasparakis M; Silke J; Meier P
Mol Cell; 2017 Jun; 66(5):698-710.e5. PubMed ID: 28506461
[TBL] [Abstract][Full Text] [Related]
23. MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death.
Dondelinger Y; Delanghe T; Rojas-Rivera D; Priem D; Delvaeye T; Bruggeman I; Van Herreweghe F; Vandenabeele P; Bertrand MJM
Nat Cell Biol; 2017 Oct; 19(10):1237-1247. PubMed ID: 28920952
[TBL] [Abstract][Full Text] [Related]
24. Survival of Single Positive Thymocytes Depends upon Developmental Control of RIPK1 Kinase Signaling by the IKK Complex Independent of NF-κB.
Webb LV; Barbarulo A; Huysentruyt J; Vanden Berghe T; Takahashi N; Ley S; Vandenabeele P; Seddon B
Immunity; 2019 Feb; 50(2):348-361.e4. PubMed ID: 30737145
[TBL] [Abstract][Full Text] [Related]
25. The E3 Ubiquitin-Protein Ligase RNF4 Promotes TNF-α-Induced Cell Death Triggered by RIPK1.
Shimada T; Kudoh Y; Noguchi T; Kagi T; Suzuki M; Tsuchida M; Komatsu H; Takahashi M; Hirata Y; Matsuzawa A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071450
[TBL] [Abstract][Full Text] [Related]
26. RIPK1 suppresses apoptosis mediated by TNF and caspase-3 in intervertebral discs.
Qiu X; Zhuang M; Lu Z; Liu Z; Cheng D; Zhu C; Liu J
J Transl Med; 2019 Apr; 17(1):135. PubMed ID: 31029152
[TBL] [Abstract][Full Text] [Related]
27. Furosine, a Maillard Reaction Product, Triggers Necroptosis in Hepatocytes by Regulating the RIPK1/RIPK3/MLKL Pathway.
Li H; Wang Y; Yang H; Zhang Y; Xing L; Wang J; Zheng N
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31091743
[TBL] [Abstract][Full Text] [Related]
28. RIPK1 is not essential for TNFR1-induced activation of NF-kappaB.
Wong WW; Gentle IE; Nachbur U; Anderton H; Vaux DL; Silke J
Cell Death Differ; 2010 Mar; 17(3):482-7. PubMed ID: 19927158
[TBL] [Abstract][Full Text] [Related]
29. Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation.
Laurien L; Nagata M; Schünke H; Delanghe T; Wiederstein JL; Kumari S; Schwarzer R; Corona T; Krüger M; Bertrand MJM; Kondylis V; Pasparakis M
Nat Commun; 2020 Apr; 11(1):1747. PubMed ID: 32269263
[TBL] [Abstract][Full Text] [Related]
30. RIPK1 and RIPK3: critical regulators of inflammation and cell death.
Newton K
Trends Cell Biol; 2015 Jun; 25(6):347-53. PubMed ID: 25662614
[TBL] [Abstract][Full Text] [Related]
31. Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation.
Shindo R; Kakehashi H; Okumura K; Kumagai Y; Nakano H
Biochem Biophys Res Commun; 2013 Jun; 436(2):212-6. PubMed ID: 23727581
[TBL] [Abstract][Full Text] [Related]
32. A murder mystery in the liver: who done it and how?
Dara L; Liu ZX; Kaplowitz N
J Clin Invest; 2016 Nov; 126(11):4068-4071. PubMed ID: 27760053
[TBL] [Abstract][Full Text] [Related]
33. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
[TBL] [Abstract][Full Text] [Related]
34. Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice.
Berger SB; Kasparcova V; Hoffman S; Swift B; Dare L; Schaeffer M; Capriotti C; Cook M; Finger J; Hughes-Earle A; Harris PA; Kaiser WJ; Mocarski ES; Bertin J; Gough PJ
J Immunol; 2014 Jun; 192(12):5476-80. PubMed ID: 24821972
[TBL] [Abstract][Full Text] [Related]
35. The Receptor Interacting Protein Kinases in the Liver.
Dara L
Semin Liver Dis; 2018 Feb; 38(1):73-86. PubMed ID: 29471568
[TBL] [Abstract][Full Text] [Related]
36. RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury.
Krishna-Subramanian S; Singer S; Armaka M; Banales JM; Holzer K; Schirmacher P; Walczak H; Kollias G; Pasparakis M; Kondylis V
Cell Death Differ; 2019 Dec; 26(12):2710-2726. PubMed ID: 30988397
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of Sirt1 in mouse livers protects against endotoxemic liver injury by acetylating and activating NF-κB.
Cui X; Chen Q; Dong Z; Xu L; Lu T; Li D; Zhang J; Zhang M; Xia Q
Cell Death Dis; 2016 Oct; 7(10):e2403. PubMed ID: 27711079
[TBL] [Abstract][Full Text] [Related]
38. RIPK1 promotes death receptor-independent caspase-8-mediated apoptosis under unresolved ER stress conditions.
Estornes Y; Aguileta MA; Dubuisson C; De Keyser J; Goossens V; Kersse K; Samali A; Vandenabeele P; Bertrand MJ
Cell Death Dis; 2014 Dec; 5(12):e1555. PubMed ID: 25476903
[TBL] [Abstract][Full Text] [Related]
39. PARP2 deficiency affects invariant-NKT-cell maturation and protects mice from concanavalin A-induced liver injury.
Filliol A; Piquet-Pellorce C; Dion S; Genet V; Lucas-Clerc C; Dantzer F; Samson M
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G399-G409. PubMed ID: 28751426
[TBL] [Abstract][Full Text] [Related]
40. 15d-PGJ2 alleviates ConA-induced acute liver injury in mice by up-regulating HO-1 and reducing hepatic cell autophagy.
Chen K; Li J; Li S; Feng J; Wu L; Liu T; Zhang R; Xu S; Cheng K; Zhou Y; Zhou S; Wang F; Dai W; Xia Y; Lu J; Zhou Y; Guo C
Biomed Pharmacother; 2016 May; 80():183-192. PubMed ID: 27133055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
